Your browser doesn't support javascript.
loading
Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.
Wang, Ding; Braiteh, Fadi; Lee, James J; Denlinger, Crystal S; Shepard, Dale R; Chaudhary, Archana; Lin, Yong; Gao, Ling; Asakiewicz, Christopher; Nasroulah, Federico; LoRusso, Patricia.
Afiliación
  • Wang D; Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI, 48202, USA. dwang1@hfhs.org.
  • Braiteh F; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA.
  • Lee JJ; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Denlinger CS; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Shepard DR; Cleveland Clinic, Cleveland, OH, USA.
  • Chaudhary A; Eli Lilly and Company, Indianapolis, IN, USA.
  • Lin Y; Eli Lilly and Company, Indianapolis, IN, USA.
  • Gao L; Eli Lilly and Company, Bridgewater, NJ, USA.
  • Asakiewicz C; Eli Lilly and Company, Bridgewater, NJ, USA.
  • Nasroulah F; Eli Lilly and Company, Bridgewater, NJ, USA.
  • LoRusso P; Yale Cancer Center, New Haven, CT, USA.
Cancer Chemother Pharmacol ; 78(4): 727-33, 2016 10.
Article en En | MEDLINE | ID: mdl-27507037

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Camptotecina / Anticuerpos Monoclonales / Neoplasias / Antineoplásicos / Antineoplásicos Fitogénicos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Camptotecina / Anticuerpos Monoclonales / Neoplasias / Antineoplásicos / Antineoplásicos Fitogénicos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos